肺部真菌感染治疗指南(2011年更新)

2011-11-11 MedSci原创 MedSci原创

 2011年1月1日,美国胸科学会(ATS)发布了新版成人肺部真菌感染治疗指南,就新药、新治疗手段及新出现的真菌种类进行了介绍,为1988年ATS肺部真菌感染指南发布以来的首次更新。   美国ATS真菌感染专家组主席、梅奥医院安德鲁·林佩尔(Andrew Limper)教授说,近年来,肺部真菌感染的发病率、诊断率及临床严重程度均显著增加,除免疫抑制相关疾病(如HIV感染)患者显著增多外

 2011年1月1日,美国胸科学会(ATS)发布了新版成人肺部真菌感染治疗指南,就新药、新治疗手段及新出现的真菌种类进行了介绍,为1988年ATS肺部真菌感染指南发布以来的首次更新。   美国ATS真菌感染专家组主席、梅奥医院安德鲁·林佩尔(Andrew Limper)教授说,近年来,肺部真菌感染的发病率、诊断率及临床严重程度均显著增加,除免疫抑制相关疾病(如HIV感染)患者显著增多外,器官移植后接受免疫抑制剂或患自身免疫性疾病患者亦显著增多。另一方面,各种诊断技术包括CT、正电子体层摄影(PET)、支气管镜、纵隔镜及影像辅助的胸腔活检等的发展,增加了真菌感染诊断率。同时,新药的出现为医生提供了更多的治疗选择。ATS1988年肺部真菌感染指南仅覆盖了HIV感染者,且其后出现了诸多新药,因此,本次发布的指南几乎为全新内容。本指南覆盖了重症监护病房中日益常见的念珠菌和曲霉菌感染,并提供了新药最佳用法,为已存在及尚未出现的真菌感染提供了推荐意见。   本报现选取部分指南推荐内容进行介绍,并邀请中国医学科学院北京协和医院刘正印教授进行要点介绍及评论。   指南推荐   抗真菌药物  

评论区 (3)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1934721, encodeId=c2091934e218d, content=<a href='/topic/show?id=1072646328c' target=_blank style='color:#2F92EE;'>#治疗指南#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=64632, encryptionId=1072646328c, topicName=治疗指南)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6732482, createdName=w984445tii, createdTime=Tue Aug 07 11:24:00 CST 2012, time=2012-08-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1353660, encodeId=f750135366087, content=<a href='/topic/show?id=dddce266537' target=_blank style='color:#2F92EE;'>#真菌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72665, encryptionId=dddce266537, topicName=真菌)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Sun Nov 13 12:24:00 CST 2011, time=2011-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1360319, encodeId=503613603191a, content=<a href='/topic/show?id=ec0fe2676d0' target=_blank style='color:#2F92EE;'>#真菌感染#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72676, encryptionId=ec0fe2676d0, topicName=真菌感染)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c77e138, createdName=kalseyzl, createdTime=Sun Nov 13 12:24:00 CST 2011, time=2011-11-13, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1934721, encodeId=c2091934e218d, content=<a href='/topic/show?id=1072646328c' target=_blank style='color:#2F92EE;'>#治疗指南#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=64632, encryptionId=1072646328c, topicName=治疗指南)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6732482, createdName=w984445tii, createdTime=Tue Aug 07 11:24:00 CST 2012, time=2012-08-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1353660, encodeId=f750135366087, content=<a href='/topic/show?id=dddce266537' target=_blank style='color:#2F92EE;'>#真菌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72665, encryptionId=dddce266537, topicName=真菌)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Sun Nov 13 12:24:00 CST 2011, time=2011-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1360319, encodeId=503613603191a, content=<a href='/topic/show?id=ec0fe2676d0' target=_blank style='color:#2F92EE;'>#真菌感染#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72676, encryptionId=ec0fe2676d0, topicName=真菌感染)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c77e138, createdName=kalseyzl, createdTime=Sun Nov 13 12:24:00 CST 2011, time=2011-11-13, status=1, ipAttribution=)]
    2011-11-13 zhaojie88
  3. [GetPortalCommentsPageByObjectIdResponse(id=1934721, encodeId=c2091934e218d, content=<a href='/topic/show?id=1072646328c' target=_blank style='color:#2F92EE;'>#治疗指南#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=64632, encryptionId=1072646328c, topicName=治疗指南)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6732482, createdName=w984445tii, createdTime=Tue Aug 07 11:24:00 CST 2012, time=2012-08-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1353660, encodeId=f750135366087, content=<a href='/topic/show?id=dddce266537' target=_blank style='color:#2F92EE;'>#真菌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72665, encryptionId=dddce266537, topicName=真菌)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Sun Nov 13 12:24:00 CST 2011, time=2011-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1360319, encodeId=503613603191a, content=<a href='/topic/show?id=ec0fe2676d0' target=_blank style='color:#2F92EE;'>#真菌感染#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72676, encryptionId=ec0fe2676d0, topicName=真菌感染)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c77e138, createdName=kalseyzl, createdTime=Sun Nov 13 12:24:00 CST 2011, time=2011-11-13, status=1, ipAttribution=)]